Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
0.975
-0.085 (-8.00%)
At close: Nov 15, 2024, 4:00 PM
0.980
+0.005 (0.49%)
After-hours: Nov 15, 2024, 7:16 PM EST
Lexicon Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -216.39 | -177.12 | -101.94 | -87.76 | -58.57 | 130.13 | Upgrade
|
| Depreciation & Amortization | 0.56 | 0.55 | 0.43 | 0.29 | 2.93 | 3.65 | Upgrade
|
| Other Amortization | 2.06 | 1.77 | 0.74 | 0.05 | 1.01 | 1.47 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0 | 0.05 | -133.29 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 1.6 | 28.64 | Upgrade
|
| Stock-Based Compensation | 15.17 | 14.34 | 11.52 | 10.58 | 13.27 | 14.22 | Upgrade
|
| Other Operating Activities | -3.62 | -4.11 | - | - | -1 | -6.01 | Upgrade
|
| Change in Accounts Receivable | -2.58 | -0.98 | -0.01 | 0.38 | 53.23 | -50.61 | Upgrade
|
| Change in Inventory | -0.3 | -0.38 | - | - | 0.35 | 0.44 | Upgrade
|
| Change in Accounts Payable | 3.02 | 6.45 | 0.08 | -14.16 | -20.97 | 20.1 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | - | -25.99 | Upgrade
|
| Change in Other Net Operating Assets | -1.95 | -2.43 | 0.34 | 3.55 | -1.52 | -2.22 | Upgrade
|
| Operating Cash Flow | -207.84 | -161.9 | -88.85 | -87.02 | -142.97 | 113.81 | Upgrade
|
| Capital Expenditures | -0.56 | -0.47 | -1.33 | -1.22 | -0.09 | -0.07 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 11.01 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | 160.39 | - | Upgrade
|
| Investment in Securities | -16.62 | -49.47 | -69.75 | 3.33 | 209.45 | -155.79 | Upgrade
|
| Investing Cash Flow | -17.18 | -49.94 | -71.08 | 2.11 | 380.76 | -155.86 | Upgrade
|
| Long-Term Debt Issued | - | 49.96 | 48.87 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -11.7 | -216.58 | -1.29 | Upgrade
|
| Net Debt Issued (Repaid) | -0 | 49.96 | 48.87 | -11.7 | -216.58 | -1.29 | Upgrade
|
| Issuance of Common Stock | 0.09 | 138.82 | 94.21 | 37.08 | 69.97 | - | Upgrade
|
| Repurchase of Common Stock | -1.73 | -0.82 | -0.86 | -2.68 | -1.03 | -0.94 | Upgrade
|
| Other Financing Activities | -1.31 | - | - | - | - | - | Upgrade
|
| Financing Cash Flow | 238.45 | 187.96 | 142.21 | 22.71 | -147.64 | -2.23 | Upgrade
|
| Net Cash Flow | 13.44 | -23.88 | -17.72 | -62.2 | 90.15 | -44.27 | Upgrade
|
| Free Cash Flow | -208.39 | -162.37 | -90.18 | -88.24 | -143.06 | 113.74 | Upgrade
|
| Free Cash Flow Margin | -3985.35% | -13485.63% | -64875.54% | -29610.07% | -596.19% | 35.31% | Upgrade
|
| Free Cash Flow Per Share | -0.72 | -0.73 | -0.54 | -0.61 | -1.29 | 0.97 | Upgrade
|
| Cash Interest Paid | 13.08 | 10.06 | 2.29 | 0.8 | 17.35 | 19.21 | Upgrade
|
| Levered Free Cash Flow | -126.94 | -94.97 | -52.84 | -55.54 | 101.61 | 77.96 | Upgrade
|
| Unlevered Free Cash Flow | -118.29 | -88.56 | -51.84 | -55.09 | 109.68 | 89.42 | Upgrade
|
| Change in Net Working Capital | 1.52 | -4.36 | -0.52 | 10.31 | -41.48 | 34.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.